Home | About IJMPO | Editorial board | Search | Ahead of print | Current Issue | Archives | Instructions | Subscribe | Advertise | Contact us |  Login 
Indian Journal of Medical and Paediatric Oncology
Search Article 
Advanced search 
Year : 2020  |  Volume : 41  |  Issue : 5  |  Page : 652-653

Trastuzumab emtansine for residual invasive human epidermal growth receptor-2-positive breast cancer

1 Department of Medical Oncology, Tata Medical Centre, Kolkata, West Bengal, India
2 Department of Medical Oncology, AIIMS, New Delhi, India
3 Malignant Diseases Treatment Centre, Army Hospital Research and Referral, New Delhi, India
4 Department of Medical Oncology/Hematology/BMT, Asian Institute of Medical Sciences, Faridabad, Haryana, India

Correspondence Address:
Dr. Joydeep Ghosh
Department of Medical Oncology, Tata Medical Centre, Kolkata, West Bengal
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/ijmpo.ijmpo_255_19

Rights and Permissions

Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)

 Article Access Statistics
    PDF Downloaded30    
    Comments [Add]    

Recommend this journal